A study on cost analysis of various oral anti hypertensive drugs available in Indian market

Authors

  • Preetha Selva Assistant Professor, Saveetha Medical College & Hospital Thandalam Chennai
  • Rakshana V Second Year M.B.B.S Student, Saveetha Medical College & Hospital, SIMATS, Chennai, 602 105 India

DOI:

https://doi.org/10.7439/ijpr.v9i7.5236

Keywords:

hypertension

Abstract

Hypertension is one of the major risk factor for morbidities and mortalities associated with coronary heart disease, congestive heart failure, stroke and compromised renal function. It has become more common in developing countries like India. The prevalence of this disease in the year 2000 was 60.4 million males and 57.8 million females. Studies have shown that, the prevalence might still increase to 107.3 million males and 106.2 million females by the year 2025. Unlike that of previous misconceptions; regarding hypertension affecting only the urban population, now there is no disparity between the transition zones. The reason for this may be due to lack of awareness among patients, poor health care facility systems, lack of physicians to follow the standard treatment guidelines for management of hypertension, unhealthy life styles, non- compliance, poor dietary habits etc.

Downloads

Download data is not yet available.

Downloads

Published

2019-07-31

Issue

Section

Research Articles

How to Cite

1.
Selva P, V R. A study on cost analysis of various oral anti hypertensive drugs available in Indian market. Int J of Pharmc Res [Internet]. 2019 Jul. 31 [cited 2024 Oct. 18];9(7):e5236. Available from: https://ssjournals.co.in/index.php/ijpr/article/view/5236

Similar Articles

You may also start an advanced similarity search for this article.